CeleCor Therapeutics, Inc.

CIK 1705381 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for CeleCor Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jul 9, 2026D0001705381-26-000006
Aug 21, 2024D/A0001705381-24-000001
Aug 3, 2023D/A0001705381-23-000001
Mar 8, 2022D0001705381-22-000001
May 10, 2021D0001705381-21-000002
May 3, 2017D0001705381-17-000001